Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors

被引:21
作者
Livermore, David M.
Reynolds, Rosy
Stephens, Peter
Duckworth, Georgia
Felmingham, David
Johnson, Alan P.
Murchan, Stephen
Murphy, Olive
Gungabissoon, Usha
Waight, Pauline
Pebody, Richard
Shackcloth, Jemma
Warner, Marina
Williams, Laura
George, Robert C.
机构
[1] Hlth Protect Agcy, Ctr Infect, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
[2] British Soc Antimicrobial Chemotherapy, Birmingham B1 2JS, W Midlands, England
[3] IMS Hlth, London NW1 6JB, England
[4] GR Micro Ltd, London NW1 3ER, England
[5] Hlth Protect Surveillance Ctr, Dublin, Ireland
[6] Bon Secours Hosp, Cork, Ireland
关键词
Streptococcus pneumoniae; antibiotic control; usage and resistance trends;
D O I
10.1016/j.ijantimicag.2006.05.025
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
It is widely believed that reducing antimicrobial usage should reduce resistance, although observational evidence is mixed. Pneumococci make ideal subjects to test this belief as they are widely surveyed and lack an animal reservoir. Accordingly, susceptibility data for pneumococci in the UK and Ireland were retrieved from the Health Protection Agency's LabBase/CoSurv system and from the European Antimicrobial Resistance Surveillance System (EARSS) and British Society for Antimicrobial Chemotherapy (BSAC) databases. The BSAC surveillance examines respiratory pneumococci; the other systems focus upon invasive organisms only, with the LabBase/CoSurv system being the most comprehensive, capturing data on most bacteraemias in England and Wales. National pharmacy sales data were obtained from the IMS Health MIDAS database and were modelled to the resistance data by logistic and linear regression analysis. All systems except for the BSAC respiratory surveillance data indicated that penicillin resistance has fallen significantly since 1999 in the UK, whereas macrolide resistance has been essentially stable, or has risen slightly. The data for Ireland were based on smaller sample sizes but suggested a fall in penicillin non-susceptibility from 1999 to 2004, with conflicting evidence for macrolide resistance. The recent decreasing trend in penicillin resistance is in contrast to a rising trend in England and Wales until (at least) 1997 and strongly rising macrolide resistance from 1989 to 1993. UK pharmacy sales of macrolides and oral beta-lactams fell by ca. 30% in the late 1990s following increased concern about resistance, before stabilising or rising weakly; sales in Ireland were stable or rose slightly in the study period. We conclude that falling penicillin resistance in pneumococci followed reduced sales of oral beta-lactams to pharmacies in the UK, but a similar fall in macrolide sales was not associated with any fall in resistance. Stabilisation or decline in penicillin resistance has occurred in Ireland despite stable or increasing oral P-lactam sales. (c) 2006 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:273 / 279
页数:7
相关论文
共 15 条
[1]   BSAC standardized disc susceptibility testing method (version 4) [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) :60-76
[2]   Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man [J].
Bean, DC ;
Livermore, DM ;
Papa, I ;
Hall, LMC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (05) :962-964
[3]   Penicillin susceptibility and epidemiological typing of invasive pneumococcal isolates in the Republic of Ireland [J].
Bennett, D ;
Lennon, B ;
Humphreys, H ;
Cafferkey, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) :3641-3648
[4]   A European study on the relationship between antimicrobial use and antimicrobial resistance [J].
Bronzwaer, SLAM ;
Cars, O ;
Buchholz, U ;
Mölstad, S ;
Goettsch, W ;
Veldhuijzen, IK ;
Kool, JL ;
Sprenger, MJW ;
Degener, JE .
EMERGING INFECTIOUS DISEASES, 2002, 8 (03) :278-282
[5]   Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe [J].
Bruinsma, N ;
Kristinsson, KG ;
Bronzwaer, S ;
Schrijnemakers, P ;
Degener, J ;
Tiemersma, E ;
Hryniewicz, W ;
Monen, J ;
Grundmann, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (06) :1045-1050
[6]   Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction [J].
Enne, VI ;
Livermore, DM ;
Stephens, P ;
Hall, LMC .
LANCET, 2001, 357 (9265) :1325-1328
[7]  
Fleming DM, 2003, BRIT J GEN PRACT, V53, P778
[8]   Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: Analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns [J].
Hall, LMC ;
Whiley, RA ;
Duke, B ;
George, RC ;
Efstratiou, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :853-859
[9]   Influence of macrolide antibiotics on promotion of resistance in the oral flora of children [J].
Kastner, U ;
Guggenbichler, JP .
INFECTION, 2001, 29 (05) :251-256
[10]   Impact of the European Antimicrobial Resistance Surveillance System on the development of a national programme to monitor resistance in Staphylococcus aureus and Streptococcus pneumoniae in Ireland, 1999-2003 [J].
Murphy, OM ;
Murchan, S ;
Whyte, D ;
Humphreys, H ;
Rossney, A ;
Clarke, P ;
Cunney, R ;
Keane, C ;
Fenelon, LE ;
O'Flanagan, D .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (07) :480-483